- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
HHS’ proposed overhaul of drug rebates is expected to lead to higher Medicare Part D premiums, but CMS is helping insurers keep premiums artificially low by letting them choose to have taxpayers cover the cost of setting premiums too low for the first two years, sources say.
Advertisement
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us